NDC 70436-027 – Eptifibatide
Eptifibatide .75 mg/mL · Injection · Intravenous
Product NDC70436-027
Product details
- Brand name
- Eptifibatide
- Generic name
- Eptifibatide
- Labeler
- Slate Run Pharmaceuticals, LLC
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- ANDA · ANDA209864
- Marketed since
- July 22, 2019
- Listing expires
- December 31, 2027
- Pharmacologic class
- Platelet Aggregation Inhibitor
Active ingredients
- Eptifibatide .75 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 70436-027-80 | 100 mL in 1 VIAL (70436-027-80) | Jul 22, 2019 |
Recalls mentioning this NDC
- D-0343-2026 Mar 4, 2026 · Class III
Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved statement is 75 mg/100 mL vial for…
Other Eptifibatide products
- 0338-9558 Eptifibatide 75 mg/100mL · Injection · Baxter Healthcare Company
- 55150-218 Eptifibatide 75 mg/100mL · Injection · Eugia US LLC
- 55150-219 Eptifibatide 20 mg/10mL · Injection · Eugia US LLC
- 55150-220 Eptifibatide 200 mg/100mL · Injection · Eugia US LLC
- 70436-163 Eptifibatide .75 mg/mL · Injection · Slate Run Pharmaceuticals, LLC
- 70436-162 Eptifibatide 2 mg/mL · Injection · Slate Run Pharmaceuticals, LLC
- 70436-026 Eptifibatide 2 mg/mL · Injection · Slate Run Pharmaceuticals, LLC
- 83634-301 Eptifibatide .75 mg/mL · Injection, Solution · Avenacy, LLC
- 83634-300 Eptifibatide 2 mg/mL · Injection, Solution · Avenacy, LLC
- 52958-402 Eptifibatide 2 mg/mL · Injection, Solution · Hainan Shuangcheng Pharmaceuticals Co., Ltd.
- 52958-040 Eptifibatide .75 mg/mL · Injection, Solution · Hainan Shuangcheng Pharmaceuticals Co., Ltd.
- 71288-412 Eptifibatide 2 mg/mL · Injection, Solution · Meitheal Pharmaceuticals Inc.